speb/financial-data huggingface dataset:
Financial ratios for BES.V — annual report dated 2024-09-30
Total revenue: 2497193.333333333
Gross profit: 516471.11111111107
Operating income: -1859234.8148148146
Net income: -1899677.0370370368
Capital expenditures: 0
Operating cash flow: -340353.3333333333
Depreciation & amortization: 127154.07407407406
Net tangible assets: -122842.96296296295
Owner earnings: -1772522.9629629627
Buffett classification: The Gruesome
Stock price: 0.059259259259259255
Shares outstanding: 117243252
Book value: -272031.8518518517
Market cap (USD): 6947748.266666666
Debt to equity: -1.178628319668449
Current ratio: 0.7400158486125347
Quick ratio: 0.28889885358539263
Interest coverage ratio: -73.55214652014651
COGS to revenue (%): 79.31793649225753
R&D to revenue (%): 10.367995358344524
SG&A to revenue (%): 68.79219366571834
Free cash flow (dilution-adjusted): -686272.5925925926
Buyback yield (%): 0
Retained earnings: -11720360
Inventory turnover: 2.8126321391981923
Receivables turnover: 12.88467580118099
Capitalized R&D asset: 466296.20881319273
ROCI (R&D-adjusted, %): -462.5931164932239
Rosenberg metric: -1.0879066191301234
FCF margin (%): -27.481756555730275
Revenue growth (%): -10.333026394113148
Rule of 40 score: -37.81478294984342
Financial ratios for BES.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.059259259259259255
Shares outstanding: 117243252
Market cap (USD): 6947748.266666666
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BES.V — quarterly report dated 2024-12-31
Total revenue: 590939.8601398602
Gross profit: 160510.4895104895
Operating income: -207733.56643356645
Net income: -226138.46153846156
Capital expenditures: 0
Operating cash flow: -6709.090909090909
Depreciation & amortization: 30143.356643356645
Net tangible assets: -331902.7972027972
Owner earnings: -195995.10489510492
Buffett classification: The Gruesome
Stock price: 0.04195804195804196
Shares outstanding: 117243252
Book value: -478841.95804195805
Market cap (USD): 4919297.286713287
Debt to equity: -0.6166932459430094
Current ratio: 0.5682199759302274
Quick ratio: 0.21047728477116381
Interest coverage ratio: -13.075930979839775
COGS to revenue (%): 72.83810073794973
R&D to revenue (%): 6.466172175650025
SG&A to revenue (%): 42.480036542475894
Free cash flow (dilution-adjusted): -6709.090909090909
Buyback yield (%): 0
Retained earnings: -11290813.986013986
Inventory turnover: 0.8521241705649364
Receivables turnover: 5.185146096923436
Capitalized R&D asset: 38211.18881118881
FCF margin (%): -1.1353254978438991
Rule of 40 score: -1.1353254978438991
Financial ratios for BES.V — quarterly report dated 2025-03-31
Total revenue: 586848.9510489511
Gross profit: 222672.02797202798
Operating income: -159003.4965034965
Net income: -135516.78321678322
Capital expenditures: 0
Operating cash flow: -7939.16083916084
Depreciation & amortization: 30905.594405594406
Net tangible assets: -466888.1118881119
Owner earnings: -104611.18881118883
Buffett classification: The Gruesome
Stock price: 0.04195804195804196
Shares outstanding: 117243252
Book value: -614093.0069930069
Market cap (USD): 4919297.286713287
Debt to equity: -0.897996135069857
Current ratio: 0.5172056275202577
Quick ratio: 0.24178165935681836
Interest coverage ratio: -12.395061055385959
COGS to revenue (%): 62.05633024068332
R&D to revenue (%): 2.8308114691001127
SG&A to revenue (%): 51.35344151650274
Free cash flow (dilution-adjusted): -7939.16083916084
Buyback yield (%): 0
Retained earnings: -11426330.76923077
Inventory turnover: 0.8613313618275462
Receivables turnover: 4.318085456715926
Capitalized R&D asset: 42214.083916083924
Rosenberg metric: 1.6267889169503313
FCF margin (%): -1.3528457067138229
Revenue growth (%): -0.6922716450267624
Rule of 40 score: -2.0451173517405854
Financial ratios for BES.V — quarterly report dated 2025-06-30
Total revenue: 619653.2846715328
Gross profit: 226840.87591240875
Operating income: -150819.70802919706
Net income: -164609.4890510949
Capital expenditures: 0
Operating cash flow: 31940.145985401457
Depreciation & amortization: 31099.999999999996
Net tangible assets: -653772.2627737225
Owner earnings: -133509.4890510949
Buffett classification: The Gruesome
Stock price: 0.0364963503649635
Shares outstanding: 117243252
Book value: -805286.1313868612
Market cap (USD): 4278950.802919707
Debt to equity: -0.7511443545477784
Current ratio: 0.4483034202329616
Quick ratio: 0.266489734875651
Interest coverage ratio: -11.206975104409612
COGS to revenue (%): 63.3922902494331
R&D to revenue (%): 0.5019289100921753
SG&A to revenue (%): 43.56333009394234
Free cash flow (dilution-adjusted): 31940.145985401457
Buyback yield (%): 0
Retained earnings: -12093470.802919706
Inventory turnover: 1.2842153241125207
Receivables turnover: 4.259148697056965
Capitalized R&D asset: 26850.344852228067
Rosenberg metric: 0.25094513195590606
FCF margin (%): 5.154518950437318
Revenue growth (%): 5.589910924088088
Rule of 40 score: 10.744429874525405
Financial ratios for BES.V — annual report dated 2025-09-30
Total revenue: 2261383.45323741
Gross profit: 868876.2589928058
Operating income: -957180.5755395684
Net income: -1125857.5539568346
Capital expenditures: 0
Operating cash flow: 82366.18705035972
Depreciation & amortization: 123547.4820143885
Net tangible assets: -1182833.8129496404
Owner earnings: -1002310.071942446
Buffett classification: The Gruesome
Stock price: 0.03597122302158274
Shares outstanding: 117243252
Book value: -1356020.8633093527
Market cap (USD): 4217383.165467626
Debt to equity: -0.15681938638706455
Current ratio: 0.3627871405192439
Quick ratio: 0.22012543521169944
Interest coverage ratio: -53.62031999355177
COGS to revenue (%): 61.57766796476213
R&D to revenue (%): 7.591456557280305
SG&A to revenue (%): 57.50894833270396
Free cash flow (dilution-adjusted): 82366.18705035972
Buyback yield (%): 0
Retained earnings: -12508941.007194245
Inventory turnover: 4.206074473910662
Receivables turnover: 29.363403674952593
Capitalized R&D asset: 437975.520223821
Rosenberg metric: 1.3611164506326778
FCF margin (%): 3.642291931182382
Revenue growth (%): -9.442996541287267
Rule of 40 score: -5.8007046101048845
Financial ratios for BES.V — quarterly report dated 2025-09-30
Total revenue: 438964.02877697843
Gross profit: 251089.92805755397
Operating income: -431240.2877697842
Net income: -589476.9784172663
Capital expenditures: 0
Operating cash flow: 65955.39568345324
Depreciation & amortization: 30089.208633093527
Net tangible assets: -1182833.8129496404
Owner earnings: -559387.7697841728
Buffett classification: The Gruesome
Stock price: 0.03597122302158274
Shares outstanding: 117243252
Book value: -1356020.8633093527
Market cap (USD): 4217383.165467626
Debt to equity: -0.15681938638706455
Current ratio: 0.3627871405192439
Quick ratio: 0.22012543521169944
COGS to revenue (%): 42.799429657794676
R&D to revenue (%): 25.561328176216076
SG&A to revenue (%): 106.19214632227613
Free cash flow (dilution-adjusted): 65955.39568345324
Buyback yield (%): 0
Retained earnings: -12508941.007194245
Inventory turnover: 0.567474597338479
Receivables turnover: 5.699819708731516
Capitalized R&D asset: 119771.03653270534
Rosenberg metric: 7.796573911957043
FCF margin (%): 15.025239281499935
Revenue growth (%): -29.159735026714905
Rule of 40 score: -14.13449574521497
Financial ratios for BES.V — quarterly report dated 2025-12-31
Total revenue: 362768.6131386861
Gross profit: 157594.1605839416
Operating income: -618903.6496350365
Net income: -625686.8613138685
Capital expenditures: 0
Operating cash flow: -222546.71532846714
Depreciation & amortization: 30904.379562043792
Net tangible assets: -1330848.9051094889
Owner earnings: -594782.4817518247
Buffett classification: The Gruesome
Stock price: 0.0437956204379562
Shares outstanding: 117243252
Book value: -1520403.6496350365
Market cap (USD): 5134740.963503649
Debt to equity: -0.12062586145726764
Current ratio: 0.31727010147563395
Quick ratio: 0.17143955048649542
Interest coverage ratio: -29.003831155503864
COGS to revenue (%): 56.55793944783931
R&D to revenue (%): 47.49040730955969
SG&A to revenue (%): 144.91109532729837
Free cash flow (dilution-adjusted): -392192.700729927
Buyback yield (%): 0
Retained earnings: -13317240.875912407
Inventory turnover: 0.5850523778699598
Receivables turnover: 2.688992290004058
Capitalized R&D asset: 248484.03833429606
Rosenberg metric: -0.8332582104210637
FCF margin (%): -108.1109794302938
Revenue growth (%): -17.35800900374104
Rule of 40 score: -125.46898843403483
Financial ratios for BIOCON.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.375840696294342
Shares outstanding: 1628293737
Market cap (USD): 7125153999.885797
Buyback yield (%): 0
Retained earnings: 900342872.2141633
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BIOCON.NS — annual report dated 2023-03-31
Total revenue: 1331802679.6589525
Gross profit: 885176613.8855056
Operating income: 198185140.0730816
Net income: 78319123.02070646
Capital expenditures: 194019488.42874545
Operating cash flow: 225639464.06820953
Depreciation & amortization: 135578562.72838002
Net tangible assets: -1071278928.136419
Owner earnings: 19878197.32034105
Return on net tangible assets (%): -1.8555575768601056
Capex to operating income (%): 97.89810091573966
Buffett classification: The Gruesome
Stock price: 2.4891595615103537
P/E ratio: 51.75087217625506
Shares outstanding: 1628293737
Book value: 2739196102.314251
P/B ratio: 1.4796614674563342
Market cap (USD): 4053082924.400975
Debt to equity: 0.8012343922307993
Current ratio: 1.4492344930499255
Quick ratio: 0.9506033581256536
Effective tax rate (%): 28.324601493701927
Interest coverage ratio: 3.8832935560859188
COGS to revenue (%): 33.53545330662789
R&D to revenue (%): 4.479563933016893
SG&A to revenue (%): 4.45121226255476
Free cash flow (dilution-adjusted): -1388550.548112059
Buyback yield (%): 0.19443553267785518
Retained earnings: 1959305724.725944
Inventory turnover: 0.8640573084808068
Receivables turnover: 3.0600302250083957
Capitalized R&D asset: 59658952.49695494
ROCI (R&D-adjusted, %): 4.437866910181826
FCF margin (%): -0.10426098169945405
Rule of 40 score: -0.10426098169945405
Financial ratios for BIOCON.NS — annual report dated 2024-03-31
Total revenue: 1702338409.8812807
Gross profit: 1113946516.368869
Operating income: 172023024.34344646
Net income: 155630171.48339128
Capital expenditures: 198728864.3722269
Operating cash flow: 354227125.5546228
Depreciation & amortization: 188128072.91042092
Net tangible assets: -824487348.60295
Owner earnings: 145029380.0215853
Return on net tangible assets (%): -17.590249294586492
Capex to operating income (%): 115.52457302195887
Buffett classification: The Gruesome
Stock price: 3.156429942418426
P/E ratio: 33.02441330964984
Shares outstanding: 1628293737
Book value: 3030914977.815086
P/B ratio: 1.695723946114848
Market cap (USD): 5139595106.519194
Debt to equity: 0.6439892699447671
Current ratio: 0.9883063781024558
Quick ratio: 0.666412740578691
Effective tax rate (%): 14.909520062942565
Interest coverage ratio: 1.4721880131362892
COGS to revenue (%): 34.56374420603277
R&D to revenue (%): 5.017681286014174
SG&A to revenue (%): 6.241282632891418
Free cash flow (dilution-adjusted): 110528840.3885358
Buyback yield (%): 0
Retained earnings: 2110900587.6004317
Inventory turnover: 0.9924553490159592
Receivables turnover: 2.2784001540782586
Capitalized R&D asset: 125389413.9902041
ROCI (R&D-adjusted, %): 4.175378633686937
Rosenberg metric: 3.8346282143495594
FCF margin (%): 6.49276546584201
Revenue growth (%): 27.822119288513132
Rule of 40 score: 34.31488475435514
Financial ratios for BIOCON.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: -680745341.6149068
Buffett classification: The Gruesome
Stock price: 4.326086956521739
Shares outstanding: 1628293737
Book value: 3191591017.6779737
P/B ratio: 2.207093658932111
Market cap (USD): 7044140297.021739
Debt to equity: 0.6276497005988025
Current ratio: 0.9587728011844279
Quick ratio: 0.6446273671156779
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BIOCON.NS — quarterly report dated 2024-12-31
Gross profit: 286991490.8497494
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.247930994288378
Shares outstanding: 1628293737
Market cap (USD): 6916879433.207949
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BIOCON.NS — annual report dated 2025-03-31
Total revenue: 1759667991.582885
Gross profit: 1151999064.765022
Operating income: 190074818.79822305
Net income: 167103109.65630114
Capital expenditures: 249742810.38110822
Operating cash flow: 474772036.4741641
Depreciation & amortization: 197217675.94108018
Net tangible assets: -632873509.4692541
Owner earnings: 114577975.21627313
Return on net tangible assets (%): -18.104403723954494
Capex to operating income (%): 131.39184451688294
Buffett classification: The Gruesome
Stock price: 3.977593651534601
P/E ratio: 38.758649341990434
Shares outstanding: 1628293737
Book value: 3239712415.2443295
P/B ratio: 1.9991560981304874
Market cap (USD): 6476690831.124751
Debt to equity: 0.6625890843482184
Current ratio: 1.1362095187598542
Quick ratio: 0.7921904868213593
Effective tax rate (%): 24.234071875331285
Interest coverage ratio: 1.8315872479441253
COGS to revenue (%): 34.5331579436893
R&D to revenue (%): 4.212673230491224
SG&A to revenue (%): 8.45059194004863
Free cash flow (dilution-adjusted): 184814122.04816458
Buyback yield (%): 0
Retained earnings: 2216401683.42296
Inventory turnover: 1.0541258542718663
Receivables turnover: 2.7427977915049473
Capitalized R&D asset: 151046520.34848356
ROCI (R&D-adjusted, %): 3.573273086365337
Rosenberg metric: 0.4454867346279933
FCF margin (%): 10.502783646244403
Revenue growth (%): 3.3676959509832405
Rule of 40 score: 13.870479597227643
Financial ratios for BIOCON.NS — quarterly report dated 2025-03-31
Total revenue: 509480944.58732754
Gross profit: 337292494.73930323
Operating income: 75040916.53027822
Net income: 53705868.59948561
Capital expenditures: 0
Depreciation & amortization: 51005377.601122275
Net tangible assets: -632873509.4692541
Owner earnings: 104711246.2006079
Return on net tangible assets (%): -16.545367223289492
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.977593651534601
P/E ratio: 30.148897131824732
Shares outstanding: 1628293737
Book value: 3239712415.2443295
P/B ratio: 1.9991560981304874
Market cap (USD): 6476690831.124751
Debt to equity: 0.6625890843482184
Current ratio: 1.1362095187598542
Quick ratio: 0.7921904868213593
Effective tax rate (%): 5.628594905505341
Interest coverage ratio: 3.0221280602636535
COGS to revenue (%): 33.79683807163672
R&D to revenue (%): -0.8489938275854156
Buyback yield (%): 0
Retained earnings: 2216401683.42296
Inventory turnover: 0.2986960313114721
Receivables turnover: 0.7941289017657027
Capitalized R&D asset: -4325461.772270283
ROCI (R&D-adjusted, %): 1.3893359443875464
Rule of 40 score: 0
Financial ratios for BIOCON.NS — quarterly report dated 2025-06-30
Total revenue: 457535689.21132696
Gross profit: 293119588.11139715
Operating income: 34390358.06225135
Net income: 10437631.640533583
Capital expenditures: 0
Depreciation & amortization: 53241282.47133162
Owner earnings: 63678914.1118652
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.151649894687574
P/E ratio: 105.39034347113552
Shares outstanding: 1628293737
Market cap (USD): 6760105521.7364855
Effective tax rate (%): 7.946336429308564
Interest coverage ratio: 1.0621611853993496
COGS to revenue (%): 35.935142323725735
R&D to revenue (%): -0.8848878545305747
Buyback yield (%): 0
Capitalized R&D asset: -6946737.131394879
Revenue growth (%): -10.195720944593035
Rule of 40 score: -10.195720944593035
Financial ratios for BIOCON.NS — quarterly report dated 2025-09-30
Total revenue: 480552423.90078914
Gross profit: 306144306.6516347
Operating income: 40856820.74408117
Net income: 14971815.107102593
Capital expenditures: 0
Depreciation & amortization: 53325817.36189403
Net tangible assets: -110811724.91544531
Owner earnings: 68297632.46899661
Return on net tangible assets (%): -61.63394038050667
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.8397970687711385
P/E ratio: 79.02790364923271
Shares outstanding: 1628293737
Book value: 3726629086.80947
P/B ratio: 1.6777407605606078
Market cap (USD): 6252317518.431003
Debt to equity: 0.5002389941673322
Current ratio: 1.1554613576798611
Quick ratio: 0.8000578312067035
Effective tax rate (%): 22.47518972562755
Interest coverage ratio: 1.331373989713446
COGS to revenue (%): 36.29325513196481
R&D to revenue (%): -0.3096774193548387
Buyback yield (%): 0
Inventory turnover: 0.267795319207866
Receivables turnover: 0.7723039570952311
Capitalized R&D asset: -5628178.818294722
ROCI (R&D-adjusted, %): 0.814452732195306
Revenue growth (%): 5.030587827834169
Rule of 40 score: 5.030587827834169
Financial ratios for BIOCON.NS — quarterly report dated 2025-12-31
Total revenue: 464854628.4950429
Gross profit: 315662247.9670269
Operating income: 35446140.13590287
Net income: 16018714.49259218
Capital expenditures: 0
Depreciation & amortization: 57402250.19494263
Owner earnings: 73420964.68753481
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.382644536036538
P/E ratio: 75.01240787916801
Shares outstanding: 1628293737
Market cap (USD): 7136232649.525565
Interest coverage ratio: 1.5159599809433064
COGS to revenue (%): 32.094416486939856
R&D to revenue (%): -1.2724658519051042
Buyback yield (%): 0
Capitalized R&D asset: -8248248.835249775
Revenue growth (%): -3.2666145512954605
Rule of 40 score: -3.2666145512954605
Financial ratios for BSV.L — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.007894736842105263
Shares outstanding: 415995791
Market cap (USD): 3284177.297368421
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BSV.L — annual report dated 2023-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.007901234567901235
Shares outstanding: 415995791
Market cap (USD): 3286880.3239506176
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BSV.L — annual report dated 2024-03-31
Total revenue: 14412658.227848101
Net income: 13440506.329113923
Capital expenditures: 0
Operating cash flow: -941772.1518987342
Net tangible assets: 277974683.5443038
Owner earnings: 13440506.329113923
Return on net tangible assets (%): 4.835154826958106
Buffett classification: The Gruesome
Stock price: 0.008734177215189872
P/E ratio: 0.2703306609436806
Shares outstanding: 415995791
Book value: 277974683.5443038
P/B ratio: 0.013070906001366117
Market cap (USD): 3633380.959367088
Debt to equity: 0
Effective tax rate (%): 0
COGS to revenue (%): 0
SG&A to revenue (%): 6.288424380818548
Free cash flow (dilution-adjusted): -941772.1518987342
Buyback yield (%): 99.95223760551832
Receivables turnover: 33.68639053254438
Capitalized R&D asset: 0
FCF margin (%): -6.534340418057264
Rule of 40 score: -6.534340418057264
Financial ratios for BSV.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 329078666.6666667
Buffett classification: The Gruesome
Stock price: 0.0092
Shares outstanding: 415995791
Book value: 329078666.6666667
P/B ratio: 0.011629928235599187
Market cap (USD): 3827161.2772
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BSV.L — annual report dated 2024-12-31
Total revenue: 4201250
Net income: 3262500
Capital expenditures: 0
Operating cash flow: -1863750
Net tangible assets: 200563750
Owner earnings: 3262500
Return on net tangible assets (%): 1.626664838486516
Buffett classification: The Gruesome
Stock price: 0.008624999999999999
P/E ratio: 1.099758987701149
Shares outstanding: 415995791
Book value: 200563750
P/B ratio: 0.017889392761029844
Market cap (USD): 3587963.6973749995
Debt to equity: 0
Effective tax rate (%): 0
COGS to revenue (%): 0
SG&A to revenue (%): 20.797381731627492
Free cash flow (dilution-adjusted): -1863750
Buyback yield (%): 142.35093860444331
Receivables turnover: 9.10840108401084
Capitalized R&D asset: 0
FCF margin (%): -44.36179708420113
Revenue growth (%): -70.85027665554189
Rule of 40 score: -115.21207373974302
Financial ratios for BSV.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 333910389.6103896
Buffett classification: The Gruesome
Stock price: 0.00922077922077922
Shares outstanding: 415995791
Book value: 333910389.6103896
P/B ratio: 0.011487529184282273
Market cap (USD): 3835805.345584415
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BSV.L — annual report dated 2025-03-31
Total revenue: 9906493.506493507
Net income: 8790909.09090909
Capital expenditures: 0
Operating cash flow: 1302597.4025974025
Net tangible assets: 333910389.6103896
Owner earnings: 8790909.09090909
Return on net tangible assets (%): 2.63271505303157
Buffett classification: The Gruesome
Stock price: 0.00922077922077922
P/E ratio: 0.43633773321022307
Shares outstanding: 415995791
Book value: 333910389.6103896
P/B ratio: 0.011487529184282273
Market cap (USD): 3835805.345584415
Debt to equity: 0
Effective tax rate (%): 0
COGS to revenue (%): 0
SG&A to revenue (%): 10.579444153120082
Free cash flow (dilution-adjusted): 1302597.4025974025
Buyback yield (%): 227.1826886188883
Receivables turnover: 22.838323353293415
Capitalized R&D asset: 0
FCF margin (%): 13.148925013109594
Revenue growth (%): 135.79871482281482
Rule of 40 score: 148.9476398359244
Financial ratios for BSV.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 383771621.6216216
Buffett classification: The Gruesome
Stock price: 0.00972972972972973
Shares outstanding: 415995791
Book value: 383771621.6216216
P/B ratio: 0.010546706392808223
Market cap (USD): 4047526.615135135
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BSV.L — annual report dated 2025-12-31
Total revenue: 7051351.3513513515
Net income: 5975675.675675676
Capital expenditures: 0
Operating cash flow: -1831081.0810810812
Net tangible assets: 241079729.72972974
Owner earnings: 5975675.675675676
Return on net tangible assets (%): 2.478713445703171
Buffett classification: The Gruesome
Stock price: 0.009864864864864865
P/E ratio: 0.6867411294210763
Shares outstanding: 415995791
Book value: 241079729.72972974
P/B ratio: 0.017022344712134034
Market cap (USD): 4103742.2625675676
Debt to equity: 0
Effective tax rate (%): 0
COGS to revenue (%): 0
SG&A to revenue (%): 14.181678804139516
Free cash flow (dilution-adjusted): -1831081.0810810812
Buyback yield (%): 129.51263809485783
Receivables turnover: 17.052287581699346
Capitalized R&D asset: 0
FCF margin (%): -25.96780375622844
Revenue growth (%): -28.82091582930597
Rule of 40 score: -54.78871958553441
Financial ratios for BTI — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 27.02
Shares outstanding: 2157561765
Market cap (USD): 58297318890.299995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BTI — annual report dated 2022-12-31
Total revenue: 33319277108.433735
Gross profit: 27832530120.48193
Operating income: 17203614457.831326
Net income: 8248192771.084338
Capital expenditures: 592771084.3373494
Operating cash flow: 12522891566.26506
Depreciation & amortization: 1572289156.626506
Net tangible assets: -64707228915.66265
Owner earnings: 9227710843.373495
Return on net tangible assets (%): -14.260710894296835
Capex to operating income (%): 3.445619441137335
Buffett classification: The Great
Stock price: 31.1
P/E ratio: 8.135136114511393
Shares outstanding: 2157561765
Book value: 91216867469.87952
P/B ratio: 0.7356114362692512
Market cap (USD): 67100170891.5
Debt to equity: 0.5697926297714966
Current ratio: 0.8631042401837226
Quick ratio: 0.5454545454545454
Effective tax rate (%): 26.576576576576578
Interest coverage ratio: 8.586289837642815
COGS to revenue (%): 16.467184957512202
R&D to revenue (%): 0.4990056047730972
SG&A to revenue (%): 4.299403362863859
Free cash flow (dilution-adjusted): 11732530120.481928
Buyback yield (%): 3.756297330131135
Retained earnings: 61683132530.12048
Inventory turnover: 0.8030329747839887
Receivables turnover: 6.332722692924204
Capitalized R&D asset: 166265060.24096388
ROCI (R&D-adjusted, %): 10.580059043959036
FCF margin (%): 35.212438980292895
Rule of 40 score: 35.212438980292895
Financial ratios for BTI — annual report dated 2023-12-31
Total revenue: 34535443037.974686
Gross profit: 28660759493.670883
Operating income: -10801265822.78481
Net income: -17960759493.670887
Capital expenditures: 513924050.6329114
Operating cash flow: 13562025316.455696
Depreciation & amortization: 30379746835.443035
Net tangible assets: -54425316455.6962
Owner earnings: 11905063291.139236
Buffett classification: The Gruesome
Stock price: 24.85
Shares outstanding: 2157561765
Book value: 67005063291.13924
P/B ratio: 0.8001695278950676
Market cap (USD): 53615409860.25
Debt to equity: 0.7505572977670306
Current ratio: 0.9051234607286417
Quick ratio: 0.590059337714541
Interest coverage ratio: -4.52199258081611
COGS to revenue (%): 17.010592676758417
R&D to revenue (%): 0.663416779679654
SG&A to revenue (%): 4.328702855257852
Free cash flow (dilution-adjusted): 12801265822.78481
Buyback yield (%): 0.25970240028388863
Retained earnings: 40034177215.18987
Inventory turnover: 0.9398541919805589
Receivables turnover: 7.534658933996134
Capitalized R&D asset: 340511514.4120787
ROCI (R&D-adjusted, %): -8.185028003110142
Rosenberg metric: 4.981379563382835
FCF margin (%): 37.06703808232232
Revenue growth (%): 3.6500369608352528
Rule of 40 score: 40.71707504315757
Financial ratios for BTI — annual report dated 2024-12-31
Total revenue: 32333750000
Gross profit: 26788750000
Operating income: 13291250000
Net income: 3976250000
Capital expenditures: 426250000
Operating cash flow: 12656250000
Depreciation & amortization: 3827500000
Net tangible assets: -55791250000
Owner earnings: 7377500000
Return on net tangible assets (%): -13.223399726659647
Capex to operating income (%): 3.206997084548105
Buffett classification: The Great
Stock price: 33.66
P/E ratio: 18.264326692209995
Shares outstanding: 2157561765
Book value: 62493750000
P/B ratio: 1.1620926734257424
Market cap (USD): 72623529009.9
Debt to equity: 0.7390739073907391
Current ratio: 0.7626313823827562
Quick ratio: 0.5163527717014352
Effective tax rate (%): 10.090446579988695
Interest coverage ratio: 5.83589462129528
COGS to revenue (%): 17.149263540418293
R&D to revenue (%): 0.6726717439208257
SG&A to revenue (%): 4.411025631113001
Free cash flow (dilution-adjusted): 11896250000
Buyback yield (%): 1.363194564484802
Retained earnings: 32522500000
Inventory turnover: 0.9610051993067591
Receivables turnover: 7.177302996670366
Capitalized R&D asset: 425873798.9934421
ROCI (R&D-adjusted, %): 10.590960405612732
Rosenberg metric: -8.170649171270707
FCF margin (%): 36.792051648818955
Revenue growth (%): -6.375169519481001
Rule of 40 score: 30.416882129337953
Financial ratios for BTI — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -55791250000
Buffett classification: The Gruesome
Stock price: 33.66
Shares outstanding: 2157561765
Book value: 62493750000
P/B ratio: 1.1620926734257424
Market cap (USD): 72623529009.9
Debt to equity: 0.7390739073907391
Current ratio: 0.7626313823827562
Quick ratio: 0.5163527717014352
Buyback yield (%): 0
Retained earnings: 32522500000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BTI — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -53902739726.0274
Buffett classification: The Gruesome
Stock price: 45.38
Shares outstanding: 2157561765
Book value: 64626027397.260284
P/B ratio: 1.515026636154503
Market cap (USD): 97910152895.70001
Debt to equity: 0.7462958645102485
Current ratio: 0.8674043510877719
Quick ratio: 0.5493248312078018
Buyback yield (%): 0
Retained earnings: 31498630136.9863
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BYAH — quarterly report dated 2025-04-30
Capital expenditures: 0
Net tangible assets: 583694.6354883082
Buffett classification: The Gruesome
Stock price: 716
Shares outstanding: 5983216
Book value: 584654.7455295736
P/B ratio: 7327.37173307234
Market cap (USD): 4283982656
Debt to equity: 0.021518242817214216
Current ratio: 3.6766820371155524
Quick ratio: 3.6333482999897297
Buyback yield (%): 0
Retained earnings: -2691087.3452544706
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCN.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 85.39772727272728
Shares outstanding: 3488241
Market cap (USD): 297887853.5795455
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCN.PA — annual report dated 2022-12-31
Total revenue: 369774468.08510643
Net income: 86957446.80851065
Capital expenditures: 26552127.65957447
Operating cash flow: -149970212.76595744
Depreciation & amortization: 19042553.19148936
Net tangible assets: 2871000000
Owner earnings: 79447872.34042552
Return on net tangible assets (%): 2.7672543483255145
Buffett classification: The Gruesome
Stock price: 62.04255319148937
P/E ratio: 2.4887963679960854
Shares outstanding: 3488241
Book value: 2871187234.042553
P/B ratio: 0.07537626777565513
Market cap (USD): 216419377.78723407
Debt to equity: 0.2614445947928724
Effective tax rate (%): 14.382234326716597
COGS to revenue (%): 0
SG&A to revenue (%): 21.038413293899673
Free cash flow (dilution-adjusted): -176522340.42553192
Buyback yield (%): 0
Retained earnings: 86957446.80851065
Receivables turnover: 1.5963369324105245
Capitalized R&D asset: 0
FCF margin (%): -47.73783905083029
Rule of 40 score: -47.73783905083029
Financial ratios for CCN.PA — annual report dated 2023-12-31
Total revenue: 379345555.5555555
Net income: 86351111.1111111
Capital expenditures: 44658888.88888889
Operating cash flow: -910617777.7777778
Depreciation & amortization: 21751111.111111112
Net tangible assets: 3192713333.3333335
Owner earnings: 63443333.33333332
Return on net tangible assets (%): 1.9871290250507923
Buffett classification: The Gruesome
Stock price: 78.4
P/E ratio: 3.1670477760049414
Shares outstanding: 3488241
Book value: 3193962222.2222214
P/B ratio: 0.08562345931872849
Market cap (USD): 273478094.40000004
Debt to equity: 0.46344074201114194
Effective tax rate (%): 12.522371427606622
COGS to revenue (%): 0
SG&A to revenue (%): 22.974362278895526
Free cash flow (dilution-adjusted): -955276666.6666666
Buyback yield (%): 0
Retained earnings: 86345555.55555555
Receivables turnover: 1.4401091646876698
Capitalized R&D asset: 0
FCF margin (%): -251.82229043586761
Revenue growth (%): 2.5883581200220216
Rule of 40 score: -249.2339323158456
Financial ratios for CCN.PA — annual report dated 2024-12-31
Total revenue: 367846875
Net income: 81972916.66666667
Capital expenditures: 29175000
Operating cash flow: 34518750
Depreciation & amortization: 21972916.666666668
Net tangible assets: 3202694791.666667
Owner earnings: 74770833.33333334
Return on net tangible assets (%): 2.334622503770425
Buffett classification: The Gruesome
Stock price: 83.70833333333334
P/E ratio: 3.562089190535492
Shares outstanding: 3488241
Book value: 3203815625
P/B ratio: 0.09113971418845303
Market cap (USD): 291994840.37500006
Debt to equity: 0.343539262916646
Effective tax rate (%): 6.362370747611284
COGS to revenue (%): 0
SG&A to revenue (%): 21.297075039715914
Free cash flow (dilution-adjusted): 5343750
Buyback yield (%): 0
Retained earnings: 81965625
Receivables turnover: 1.597417049284147
Capitalized R&D asset: 0
FCF margin (%): 1.452710451869409
Revenue growth (%): -3.031188948217829
Rule of 40 score: -1.57847849634842
Financial ratios for CCN.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 3202694791.666667
Buffett classification: The Gruesome
Stock price: 83.70833333333334
Shares outstanding: 3488241
Book value: 3203815625
P/B ratio: 0.09113971418845303
Market cap (USD): 291994840.37500006
Debt to equity: 0.343539262916646
Buyback yield (%): 0
Retained earnings: 81965625
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCN.PA — quarterly report dated 2025-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 102.75
Shares outstanding: 3488241
Market cap (USD): 358416762.75
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCN.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 3784357647.0588236
Buffett classification: The Gruesome
Stock price: 114.07058823529411
Shares outstanding: 3488241
Book value: 3785623529.411766
P/B ratio: 0.10510968660380754
Market cap (USD): 397905702.77647054
Debt to equity: 0.3887773558167431
Buyback yield (%): 0
Retained earnings: 70051764.70588236
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLN.SW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.384615384615383
Shares outstanding: 328875656
Market cap (USD): 5717376788.923077
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLN.SW — annual report dated 2022-12-31
Total revenue: 5650000000
Gross profit: 1114130434.7826087
Operating income: 33695652.17391304
Net income: 126086956.52173913
Capital expenditures: 217391304.34782606
Operating cash flow: 545652173.9130435
Depreciation & amortization: 300000000
Net tangible assets: 1460869565.2173913
Owner earnings: 208695652.17391306
Return on net tangible assets (%): 14.285714285714288
Capex to operating income (%): 645.1612903225807
Buffett classification: The Gruesome
Stock price: 13.554347826086957
P/E ratio: 35.354133020000006
Shares outstanding: 328875656
Book value: 2731521739.130435
P/B ratio: 1.6319456547234379
Market cap (USD): 4457695032.956522
Debt to equity: 0.5825706327099085
Current ratio: 1.433404940923738
Quick ratio: 1.0059076262083781
Effective tax rate (%): 1783.3333333333333
Interest coverage ratio: 0.369047619047619
COGS to revenue (%): 80.2808772604848
R&D to revenue (%): 3.0781069642170067
SG&A to revenue (%): 16.04463255098115
Free cash flow (dilution-adjusted): 315217391.3043478
Buyback yield (%): 0.1950705938747393
Retained earnings: 2881521739.1304345
Inventory turnover: 5.242462311557789
Receivables turnover: 7.169655172413794
Capitalized R&D asset: 173913043.47826087
ROCI (R&D-adjusted, %): 3.068806657750037
FCF margin (%): 5.579068872643324
Rule of 40 score: 5.579068872643324
Financial ratios for CLN.SW — annual report dated 2023-12-31
Total revenue: 5210714285.714286
Gross profit: 1320238095.2380953
Operating income: 285714285.71428573
Net income: 213095238.0952381
Capital expenditures: 235714285.71428573
Operating cash flow: 501190476.19047624
Depreciation & amortization: 280952380.95238096
Net tangible assets: 1317857142.857143
Owner earnings: 258333333.3333333
Return on net tangible assets (%): 19.602529358626917
Capex to operating income (%): 82.5
Buffett classification: The Gruesome
Stock price: 13
P/E ratio: 20.0632523101676
Shares outstanding: 328875656
Book value: 2595238095.2380953
P/B ratio: 1.6473954878532109
Market cap (USD): 4275383528
Debt to equity: 0.6188073394495412
Current ratio: 1.3958464443045941
Quick ratio: 1.0031466331025802
Effective tax rate (%): 2.293577981651376
Interest coverage ratio: 2.2222222222222223
COGS to revenue (%): 74.66301119488233
R&D to revenue (%): 3.655471784327165
SG&A to revenue (%): 16.198309344299748
Free cash flow (dilution-adjusted): 254761904.76190478
Buyback yield (%): 0.22275918549615378
Retained earnings: 3197619047.6190476
Inventory turnover: 5.237179487179487
Receivables turnover: 7.71957671957672
Capitalized R&D asset: 306997929.60662526
ROCI (R&D-adjusted, %): 7.419821895403608
Rosenberg metric: 1.1851190476190476
FCF margin (%): 4.8891935115375835
Revenue growth (%): -7.774968394437419
Rule of 40 score: -2.8857748828998355
Financial ratios for CLN.SW — annual report dated 2024-12-31
Total revenue: 4613333333.333333
Gross profit: 1398888888.8888888
Operating income: 427777777.7777778
Net income: 311111111.1111111
Capital expenditures: 221111111.1111111
Operating cash flow: 464444444.4444444
Depreciation & amortization: 274444444.4444444
Net tangible assets: 743333333.3333334
Owner earnings: 364444444.4444445
Return on net tangible assets (%): 49.02840059790733
Capex to operating income (%): 51.688311688311686
Buffett classification: The Good
Stock price: 10.144444444444446
P/E ratio: 10.723695497428572
Shares outstanding: 328875656
Book value: 2786666666.666667
P/B ratio: 1.1972227828070174
Market cap (USD): 3336260821.4222226
Debt to equity: 0.7511961722488038
Current ratio: 1.4665747760165402
Quick ratio: 1.0192970365265333
Effective tax rate (%): 24.324324324324326
Interest coverage ratio: 4.8734177215189876
COGS to revenue (%): 69.67726396917149
R&D to revenue (%): 3.034682080924856
SG&A to revenue (%): 18.015414258188827
Free cash flow (dilution-adjusted): 232222222.2222222
Buyback yield (%): 0.46625717796621013
Retained earnings: 3367777777.7777777
Inventory turnover: 4.4576271186440675
Receivables turnover: 6.538582677165354
Capitalized R&D asset: 325010351.96687376
ROCI (R&D-adjusted, %): 7.045001928254339
Rosenberg metric: 0.41291666666666615
FCF margin (%): 5.033718689788054
Revenue growth (%): -11.46447338359608
Rule of 40 score: -6.430754693808026
Financial ratios for CLN.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 743333333.3333334
Buffett classification: The Gruesome
Stock price: 10.144444444444446
Shares outstanding: 328875656
Book value: 2786666666.666667
P/B ratio: 1.1972227828070174
Market cap (USD): 3336260821.4222226
Debt to equity: 0.7511961722488038
Current ratio: 1.4665747760165402
Quick ratio: 1.0192970365265333
Buyback yield (%): 0
Retained earnings: 3367777777.7777777
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLN.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 515000000
Buffett classification: The Gruesome
Stock price: 9.975
Shares outstanding: 328875656
Market cap (USD): 3280534668.6
Current ratio: 1.3647514525500324
Quick ratio: 1.3647514525500324
Buyback yield (%): 0
Retained earnings: 3756250000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COASTCORP.NS — annual report dated 2022-03-31
Total revenue: 62190531.45193195
Gross profit: 12772148.226295661
Operating income: 1680588.1577212187
Net income: 1787300.540683107
Capital expenditures: 0
Depreciation & amortization: 568086.509297112
Owner earnings: 2355387.049980219
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.8653567189766584
P/E ratio: 32.428343571581415
Shares outstanding: 66977230
Market cap (USD): 57959195.99894502
Effective tax rate (%): 29.947640731685887
Interest coverage ratio: 2.4870999219359877
COGS to revenue (%): 79.46287332153214
R&D to revenue (%): 0
SG&A to revenue (%): 10.822942262656523
Buyback yield (%): 0
Retained earnings: 21072411.97415271
Inventory turnover: 129.50635886093448
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COASTCORP.NS — annual report dated 2023-03-31
Total revenue: 41000048.72107187
Gross profit: 10731644.336175397
Operating income: 1305176.6138855056
Net income: 815956.1510353228
Capital expenditures: 5597198.538367844
Operating cash flow: 3341729.5980511573
Depreciation & amortization: 1139049.9390986601
Net tangible assets: 29755188.794153474
Owner earnings: -3642192.4482338615
Return on net tangible assets (%): -12.240528781149953
Capex to operating income (%): 428.84606411273387
Buffett classification: The Gruesome
Stock price: 0.42228989037758835
P/E ratio: 34.66339101507688
Shares outstanding: 66977230
Book value: 29806443.361753963
P/B ratio: 0.9489158693380638
Market cap (USD): 28283807.11449452
Debt to equity: 0.7184477683666727
Current ratio: 1.275490994726274
Quick ratio: 0.5687392616783624
Effective tax rate (%): 37.74742124337887
Interest coverage ratio: 1.0113637436173326
COGS to revenue (%): 73.82528882054743
R&D to revenue (%): 0.019518113522339176
SG&A to revenue (%): 10.907565541646958
Free cash flow (dilution-adjusted): -11595870.889159562
Buyback yield (%): 0
Retained earnings: 20067210.718635812
Inventory turnover: 2.1407462093834826
Receivables turnover: 12.742429920693507
Capitalized R&D asset: 8002.436053593179
ROCI (R&D-adjusted, %): 3.8550714148280125
FCF margin (%): -28.28257831605916
Revenue growth (%): -34.073487130815955
Rule of 40 score: -62.356065446875114
Financial ratios for COASTCORP.NS — annual report dated 2024-03-31
Total revenue: 49516608.70607986
Gross profit: 11118287.56445617
Operating income: 1974001.6788583763
Net income: 542259.2637006835
Capital expenditures: 9967238.277970979
Operating cash flow: -7441791.581724428
Depreciation & amortization: 1450089.9388415876
Net tangible assets: 31038805.612183716
Owner earnings: -7974889.0754287075
Return on net tangible assets (%): -25.693285930752154
Capex to operating income (%): 504.92552183315917
Buffett classification: The Gruesome
Stock price: 0.5650191938579655
P/E ratio: 69.78842600709974
Shares outstanding: 66977230
Book value: 31112903.225806445
P/B ratio: 1.2163255941364708
Market cap (USD): 37843420.50143954
Debt to equity: 1.2831380166929727
Current ratio: 1.2717575162997936
Quick ratio: 0.5913139984057881
Effective tax rate (%): 42.966513211830744
Interest coverage ratio: 1.122260173576313
COGS to revenue (%): 77.54634686221755
R&D to revenue (%): 0.005666971003998363
SG&A to revenue (%): 6.266773870904463
Free cash flow (dilution-adjusted): -17438253.987288643
Buyback yield (%): 0
Retained earnings: 20150629.571891114
Inventory turnover: 1.9236034057369835
Receivables turnover: 7.070119205388727
Capitalized R&D asset: 8167.7240134443055
ROCI (R&D-adjusted, %): 4.266870721553576
Rosenberg metric: 48.31569108348781
FCF margin (%): -35.21697960132617
Revenue growth (%): 20.77207284056453
Rule of 40 score: -14.444906760761643
Financial ratios for COASTCORP.NS — annual report dated 2025-03-31
Total revenue: 73441512.74257657
Gross profit: 27027764.788403083
Operating income: 2117079.728781856
Net income: 523918.6345569324
Capital expenditures: 6723111.99438859
Operating cash flow: 571253.2148702361
Depreciation & amortization: 1451975.6838905774
Net tangible assets: 30605611.409866728
Owner earnings: -4747217.67594108
Return on net tangible assets (%): -15.510938867931445
Capex to operating income (%): 317.56536624423643
Buffett classification: The Gruesome
Stock price: 0.41124985412533555
P/E ratio: 52.57376670809348
Shares outstanding: 66977230
Book value: 30686637.830254853
P/B ratio: 0.897601627769799
Market cap (USD): 27544376.06721905
Debt to equity: 1.5672037593311834
Current ratio: 1.0651582611855417
Quick ratio: 0.4289353328768149
Effective tax rate (%): 40.335228256094155
Interest coverage ratio: 0.8344045891215702
COGS to revenue (%): 63.19824608850389
R&D to revenue (%): 0
SG&A to revenue (%): 7.083472682363641
Free cash flow (dilution-adjusted): -6171849.427168576
Buyback yield (%): 0
Retained earnings: 20047556.698620528
Inventory turnover: 1.6575750301122452
Receivables turnover: 10.629614150739076
Capitalized R&D asset: 4520.885442235456
ROCI (R&D-adjusted, %): 4.833718567308973
Rosenberg metric: 5669.620964550995
FCF margin (%): -8.403761301597676
Revenue growth (%): 48.316927717142114
Rule of 40 score: 39.91316641554444
Financial ratios for COASTCORP.NS — quarterly report dated 2025-03-31
Total revenue: 18362953.004442364
Gross profit: 7293348.141220481
Operating income: 145849.89478606498
Net income: -120621.93126022912
Capital expenditures: 0
Depreciation & amortization: 378127.19195697916
Net tangible assets: 30605611.409866728
Owner earnings: 257505.26069675005
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.41124985412533555
Shares outstanding: 66977230
Book value: 30686637.830254853
P/B ratio: 0.897601627769799
Market cap (USD): 27544376.06721905
Debt to equity: 1.5672037593311834
Current ratio: 1.0651582611855417
Quick ratio: 0.4289353328768149
Effective tax rate (%): 2267.6470588235293
Interest coverage ratio: 0.22153562042758715
COGS to revenue (%): 60.28226974465342
Buyback yield (%): 0
Retained earnings: 20047556.698620528
Inventory turnover: 0.39532900106671454
Receivables turnover: 2.6577762060750447
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.3336067932140591
Rule of 40 score: 0
Financial ratios for COASTCORP.NS — quarterly report dated 2025-06-30
Total revenue: 21490568.68710508
Gross profit: 8444032.295810906
Operating income: 1474842.0313597005
Net income: 673437.8656681489
Capital expenditures: 0
Depreciation & amortization: 407149.54364615027
Owner earnings: 1080587.409314299
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.44582260706763405
P/E ratio: 11.084899147727274
Shares outstanding: 66977230
Market cap (USD): 29859963.292768553
Effective tax rate (%): 24.95697074010327
Interest coverage ratio: 1.9636374966893606
COGS to revenue (%): 60.70819521459405
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 17.032204362261787
Rule of 40 score: 17.032204362261787
Financial ratios for COASTCORP.NS — quarterly report dated 2025-09-30
Total revenue: 18002626.832018036
Gross profit: 7846358.511837655
Operating income: 909560.3156708004
Net income: 413359.6392333709
Capital expenditures: 0
Depreciation & amortization: 346414.8816234498
Net tangible assets: 30483494.926719278
Owner earnings: 759774.5208568207
Return on net tangible assets (%): 2.492412771840233
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.39740698985343853
P/E ratio: 16.098100078412656
Shares outstanding: 66977230
Book value: 30564137.542277344
P/B ratio: 0.8708644019875773
Market cap (USD): 26617219.36302142
Debt to equity: 1.5374242126358195
Current ratio: 1.0296476819340032
Quick ratio: 0.35427565102456704
Effective tax rate (%): 46.3867930046207
Interest coverage ratio: 1.1406314063140632
COGS to revenue (%): 56.41547989050828
Buyback yield (%): 0
Inventory turnover: 0.3150544418339347
Receivables turnover: 3.2946741191447395
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1435120620709314
Revenue growth (%): -16.230104963112964
Rule of 40 score: -16.230104963112964
Financial ratios for COASTCORP.NS — quarterly report dated 2025-12-31
Total revenue: 33713801.93828674
Gross profit: 12074256.433106828
Operating income: 1326980.0601537263
Net income: 790063.4955998664
Capital expenditures: 0
Depreciation & amortization: 580294.0848835914
Owner earnings: 1370357.5804834578
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.5069622368274479
P/E ratio: 19.333886218564672
Shares outstanding: 66977230
Market cap (USD): 33954926.33730645
Effective tax rate (%): 4.3054712271470015
Interest coverage ratio: 1.192541795975573
COGS to revenue (%): 64.1860136237117
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 87.27157015956169
Rule of 40 score: 87.27157015956169
Financial ratios for CSL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 236.17
Shares outstanding: 40465076
Market cap (USD): 9556636998.92
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0